In an editorial paper published in Oncotarget titled, "DDX41 and its unique contribution to myeloid leukemogenesis," researcher Hirotaka Matsui from the National Cancer Center Hospital in Tokyo, Japan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback